Abstract. We have demonstrated that the relaxing mechanism of papaverine in phasic muscles such as ileum, urinary bladder, and uterus is different from tonic muscles such as aorta. In this study, we examined the inhibitory mechanism of papaverine on carbachol ( ] i level induced by papaverine or dibutyryl-cAMP. These results suggested that the relaxing mechanism of papaverine in the bovine trachea is mainly due to increases of cAMP content by inhibiting phosphodiesterase and the mechanism is partially involved in the activation of BK channel by cAMP.
Introduction
On the basis of the electrophysiological and mechanical behaviors, smooth muscles were classified into phasic and tonic muscles (1 -3) . Phasic smooth muscles are electrically quiescent in the resting condition and reveal spontaneously electrical spikes. In addition, depolarization with high K + induces an initial phasic contraction followed by a decline to low steady-state level (4) . Phasic muscles include the ileum, urinary bladder, uterus, and vas deferens. In contrast, tonic smooth muscles have depolarized cells with or without low-level continuous spike activities. High K + -induced depolarization typically evokes a slowly developing sustained contraction in tonic muscles which include the aorta and trachea. The contractile diversities among different smooth muscles appear to be attributed to variations that depend on oxidative metabolism (5, 6) , as well as cellular protein expression (7 -12) and electrophysiological response (13, 14) .
The relaxing mechanism of papaverine, a non-selective smooth muscle relaxant, has been explained by the following three modes: 1) an intracellular accumulation of cAMP and / or cGMP by inhibiting phosphodiesterase (PDE) (15 -17) , 2) an inhibition of mitochondrial respiration (18 -22) , and 3) effects on Ca 2+ movement (23) . Although these different mechanisms have been proposed by respective researchers, an effort to compare and evaluate these three concepts in various smooth muscles had been neglected up to the present. Recently, we have suggested that papaverine inhibited smooth muscle contraction mainly by the accumulation of cAMP and/ or cGMP due to the inhibition of PDE in rat aorta (24) , but by inhibiting mitochondrial respiration in guinea pig ileum (24) , urinary bladder (25) , and rat uterine (26) . These studies imply the concept that the relaxing mechanism of papaverine in phasic muscles such as ileum, urinary bladder, and uterus is different from tonic muscles such as aorta.
In the present study, we attempt to characterize the multiple mechanisms of papaverine on carbachol (CCh)-induced contraction in the bovine trachea which is classified as a tonic muscle. The investigation was performed by measuring muscle tension, cAMP or cGMP content, intracellular Ca 2+ ([Ca   2+ ] i ) level, oxidized flavoprotein as an indicator of mitochondrial respiration, pyridine nucleotides as indicator of glycolytic activity, and phosphocreatine (PCr) and ATP contents in the trachea.
Materials and Methods

Muscle preparations and tension measurement
Tracheas from adult bovines of either sex were obtained from a local abattoir. The smooth muscle was excised from cartilage, and the epithelium and connective tissues were removed. The muscle strips were about 2 mm in width and 7 mm in length and incubated with physiological salt solution (PSS) containing 136.8 mM NaCl, 5.4 mM KCl, 1.5 mM CaCl 2 , 1.0 mM MgCl 2 , 11.9 mM NaHCO 3 , and 5.5 mM glucose. PSS was aerated with 95% O 2 and 5% CO 2 to adjust pH 7.2 at 37°C.
Muscle tension was recorded isometrically. One end of each strip was bound to a glass holder and the other end was connected with a silk thread to a strain-gauge transducer (TB-611T; Nihon Kohden, Tokyo) in an organ bath containing PSS with resting tension of 3 g. The muscle strips were equilibrated for 30 min to obtain a stable contractility induced by hyperosmotically added 65 mM KCl. The developed tension was expressed as a percentage, by assigning the values at rest in normal PSS to be 0% and those at a steady level of contraction in 0.1 µM CCh to be 100%.
Assay of cAMP or cGMP content
In the muscle strips, cAMP or cGMP content were measured by enzyme immunoassay as reported previously (27) . The muscles were incubated with CCh (0.1 µM) for 15 min then with papaverine for 10 min. After incubation with papaverine, the muscles were rapidly frozen in liquid nitrogen and stored at −80°C until homogenized in 6% trichloroacetic acid (0.4 ml). The homogenate was centrifuged at 3000 × g for 15 min and the supernatant was washed with 1.5 ml of watersaturated diethylether four times; the cAMP or cGMP contents were assayed by using enzyme immunoassay kits (Amersham Pharmacia Biotech, Little Chalfont, UK). cAMP and cGMP contents are expressed as pmol / g wet weight.
Simultaneous measurement of a muscle contraction and [Ca
2+
] i level was measured simultaneously with a muscle contraction as reported previously (28) . Muscle strips were incubated with PSS containing 5 µM fura2 / AM for overnight at 4°C. The 0.02% cremophor EL, a noncytoxic detergent, was also added to increase the solubility of fura2 / AM. One end of the muscle was pinned to the bottom of the organ bath, which was filled with 8 ml of PSS, and the other end was attached to the transducer with silk thread. The muscle strip was kept horizontally in the organ bath. The muscle strip was alternately excited with light at 340 and 380 nm through the rotating filter wheel, and the 500-nm emission was measured through a band-pass filter with a fluorometer (CAF-100; Japan Spectroscopic Co., Ltd., Tokyo), and their ratio (F340 / F380) was recorded as an indicator of [Ca 2+ ] i . The fluorescence ratio was expressed as a percentage by assigning the values at rest in normal PSS to be 0% and those at a steady level of contraction in 0.1 µM CCh to be 100%.
Simultaneous measurement of muscle contraction and oxidized flavoproteins (FPox) fluorescence or reduced pyridine nucleotides (PNred) fluorescence FPox or PNred fluorescence was measured simultaneously with muscle contraction as reported previously (29) . The muscle strip was also kept horizontally in the organ bath, as described for the measurement of [Ca 2+ ] i level. The muscle strip was excited with light at 450 nm and the 530-nm emission was measured with a fluorometer (CAF-100, Japan Spectroscopic Co.) to detect FPox fluorescence. It was excited with light at 340 nm, and the 470-nm emission was measured with a fluorometer to detect PNred fluorescence. FPox or PNred fluorescence was expressed as a percentage, by assigning the values at rest in normal PSS to be 0% and those at a steady level of contraction in 0.1 µM CCh to be 100%.
Assay of PCr and ATP
PCr and ATP contents in the muscle strips were measured by the high-performance liquid chromatograph (HPLC) as reported previously (30) . The muscles were incubated with CCh (0.1 µM) for 15 min and then with papaverine, sodium cyanide (NaCN), or dibutyryl (Db)-cAMP for 10 min. After the incubation, the muscles were rapidly frozen in liquid nitrogen and stored at −80°C until homogenized in 6% perchloric acid (0.9 ml). The homogenate was centrifuged at 15,000 × g for 5 min and the supernatant neutralized with 0.2 ml of 2 M KHCO 3 . The neutralized extract was centrifuged once more and 20 µl of the supernatant was applied to the HPLC instrument.
The HPLC system (Shimadzu Corp., Kyoto) consisted of a pump (LC-10AT), a system controller (SCL-10A), an auto injector (SIL-10AF), a column oven (CTO-10A), and wave length-selectable detector (SPD-10Ai) set at 216 nm.
Chromatography was performed by µRPC C2/ C18 ST (4.6-mm internal diameter and 100-mm length, Amersham Pharmacia Biotech) using mobile phases of 50 mM KH 2 PO 4 and 5 mM terabutylammonium hydrogen sulphate (TBAHS) (pH 6.0, buffer A) and 50 mM KH 2 PO 4 , 5 mM TBAHS, and 40% methanol (pH 6.0, buffer B). Flow rate was 1.0 ml / min and the elution started with 65% buffer A. In the first 14 min, buffer B increased at a rate of 2.5%/ min. This was followed by elution with 70% buffer B for 20 min and then with 100% buffer A for 10 min. These procedures were programmed with a system controller. The sensitivity of the detecter was usually set at 1.0 a.u.f.s. and the oven temperature at 40°C. PCr and ATP contents are expressed as µmol / g wet weight.
Chemicals
Chemicals used were papaverine, CCh, Db-cAMP, iberiotoxin (IbTX) (Sigma Chemical Co., St. Louis, MO, USA); NaCN (Wako Pure Chemical, Osaka); fura2 / AM (Dojindo Laboratories, Kumamoto); and cremophor EL (Nacalai Tesque, Kyoto).
Statistics
Values are expressed as the mean ± S.E.M. and statistical analyses were performed by Student's t-test.
Results
Effects of papaverine on a CCh-induced contraction
CCh at 0.1 µM showed a sustained contraction and the addition of papaverine (30 µM) decreased CChinduced contraction to about 70% (Fig. 1A) . When the contractile response to CCh reached a steady level about 15 -20 min after, papaverine (1 -100 µM) was added cumulatively. Papaverine inhibited the CChinduced contraction in a concentration-dependent manner (Fig. 1B) . The concentration of the papaverine producing 50% relaxation (IC 50 ) on CCh-induced contraction was 10.0 (8.3 -11.0) µM.
Effects of papaverine on cAMP and cGMP contents
Papaverine (3 and 30 µM) increased cAMP content above the control in the presence of CCh (0.1 µM) in a concentration-dependent manner as shown in Fig. 2 (control, 33.4 ± 1.2 pmol / g wet wt; 3 µM, 37.0 ± 1.0 pmol / g wet wt; 30 µM, 45.6 ± 2.9 pmol / g wet wt). There was a positive correlation between the inhibition of the CCh-induced contraction and the increase of cAMP content by papaverine. However, papaverine (3 and 30 µM) did not increase cGMP content above the control in the presence of CCh (Fig. 2) .
Effects of papaverine on an elevated [Ca
The effects of papaverine on [Ca
2+
] i level was measured simultaneously with muscle tension, using a ] i level, calculated from the values just before and the steady level after the application of papaverine, were 99.1 ± 0.8% and 95.4 ± 1.0%, respectively. In the presence of 30 nM IbTX, these values were partially reversed (62.6 ± 0.8% for tension, 41.6 ± 6.9% for [Ca 2+ ] i level) (Fig. 5A) . At 1 mM, Db-cAMP, a lipophilic analog of cyclic AMP, decreased the muscle tension (93.8 ± 2.6%, P<0.01) and [Ca 2+ ] i level (85.9 ± 4.8%, P<0.01) induced by CCh. In the presence of 30 nM IbTX, these values were also restored significantly (47.4 ± 2.6% for tension, 50.4 ± 7.0% for [Ca 2+ ] i level, P<0.01, respectively) (Fig. 5B) .
Effects of papaverine on change of FPox or PNred fluorescence
Effects of papaverine were investigated on FPox or PNred fluorescence measured simultaneously with muscle tension (Fig. 6: A and B) . CCh (0.1 µM) induced a sustained muscle tension. FPox fluorescence increased slightly before an initiation of the muscle tension; however, PNred fluorescence increased slightly after the initiation of the muscle tension induced by CCh (Fig. 6:  A and B) . Although papaverine (30 µM) inhibited the CCh-induced muscle tension (FPox, 44.1 ± 3.1%; PNred, 34.9 ± 3.1%; P<0.01, respectively), papaverine did not show a remarkable effect on FPox (97.7 ± 4.1%) or PNred (95.5 ± 3.2%) fluorescence. 
Effects of papaverine on PCr and ATP contents
Effects of papaverine (30 µM), NaCN (100 µM), and Db-cAMP (1 mM) on PCr and ATP contents were summarized in Fig. 7 and Table 1 . Papaverine and NaCN decreased PCr and ATP contents below the control in the presence of CCh (0.1 µM), significantly. On the other hand, Db-cAMP did not decrease PCr and ATP contents below the control in the presence of CCh. Figure 7 shows the effects of papaverine (30 µM), NaCN (100 µM), and Db-cAMP (1 mM) on muscle tension, PCr, and ATP contents expressed as percentages of CCh-induced response. Papaverine remarkably inhibited muscle tension induced by CCh, but slightly decreased the increases in PCr and ATP contents. On the other hand, NaCN remarkably decreased the increases in PCr content, but slightly decreased muscle tension and the increase in ATP content induced by CCh. Thus, it seems that the relaxing mechanism of papaverine is little related to the decreases of PCr contents in bovine tracheal smooth muscle. As we have reported previously (24) , papaverine inhibited phenylephrine-induced contraction with increases in the cAMP and cGMP contents in rat aorta, and there was a positive correlation between the inhibition of the phenylephrine-induced contraction and the increase of cAMP or cGMP content by papaverine. In the present study, there was a positive correlation between the inhibition of the CCh-induced contraction and the increase of cAMP content by papaverine in bovine trachea, but papaverine did not increase cGMP content. However, in our experiments, papaverine (30 µM) decreased cGMP content below the control. We cannot explain this result. On the other hand, we have reported that papaverine only increased cAMP and / or cGMP contents at concentrations higher than those inducing the maximum relaxation in guinea pig ileum (24) , urinary bladder (25) and rat uterine (26) . Moreover, papaverine at only 30 µM, which induced a maximum relaxation, increased cAMP content in guinea pig taenia coli (31). These studies suggest the hypothesis that the relaxing mechanism of papaverine in tonic muscles is related with accumulation of cAMP and / or cGMP contents but not in the phasic muscles.
Currently, PDEs are classified into 11 families (32 -34) and selective PDE inhibitors have been found (35) . In many smooth muscles, cAMP PDEs are mainly PDE3 and 4. However, in aorta, milrinone, a PDE3 inhibitor, inhibited norepinephrine-induced contraction more potently than Ro20-1724, a PDE4 inhibitor (36) . On the other hand, rolipram, a PDE4 inhibitor, inhibited methacholine-or histamine-induced contraction more potently than milrinone in bovine trachea (37) . In addition, AH 21-132, a papaverine derivative compounds, inhibited PDE4 (cAMP-specific PDE) more selectively than other PDEs in bovine tracheal smooth muscle (38) . It has been reported that the inhibitory potency of papaverine or rolipram in cAMP PDE was similar, but that of milirinone was lower than those of these agents in canine trachea (39) . In bovine tracheal smooth muscle, rolipram and zaprinast, a PDE5 inhibitor, both inhibited methacholine-or histamineinduced contraction; however, zaprinast-induced relaxation was seen only at concentrations that exceeded its selectively inhibiting cGMP PDE (39) . In the present study, 30 µM papaverine, which induced a submaximum relaxation, increased cAMP content by 1.4-fold. Moreover, YM976, a novel PDE4 inhibitor, increased cAMP content by 1.3-fold at concentrations that induced a submaximum inhibition of histamine-induced contraction (40) . These results suggest that papaverine may inhibit CCh-induced contraction in the bovine trachea by accumulation of cAMP mainly due to the inhibition of PDE4.
Papaverine inhibited CCh-induced muscle contraction and the increases in [Ca 2+ ] i level in a concentrationdependent manner. In guinea pig trachea, papaverine has been shown to inhibit a Ba 2+ inward current in a manner independent of intracellular cAMP (23 ] i level by papaverine is due to a cAMP-dependent or -independent pathway. In the present study, pretreatment of IbTX, a large-conductance Ca ] i level by papaverine or Db-cAMP. It has been reported that cAMPdependent protein kinase induced hyperpolarization in plasma membrane due to the activation of BK channel in tracheal smooth muscle (41, 42 Some papers reported that the possibility that the relaxing mechanism of papaverine is involved in the inhibition of mitochondrial respiration (18 -22) . Tsuda et al. (20 -22) showed that papaverine inhibited high K + -induced contraction and O 2 consumption in guinea pig taenia coli and elucidated that papaverine inhibited mitochondrial respiration by blocking the transduction of an electron between NADH and coenzyme Q and by inhibiting NADH, NADHP-diaphorase. On the other hand, Ozaki et al. (29) reported that the high K + -induced contraction was accompanied by an increase in FPox fluorescence or PNred fluorescence in guinea pig taenia coli. They suggested that the change in FPox fluorescence represented mitochondrial respiration activity and that PNred fluorescence represented glycolysis activity. We have reported that papaverine inhibited CChinduced contraction and the increase in FPox fluorescence in guinea pig ileum (24) and urinary bladder (25) , but in rat aorta, papaverine inhibited phenylephrineinduced contraction without change of FPox fluorescence (24) . In the present study, papaverine inhibited CCh-induced contraction without changes of FPox fluorescence or PNred fluorescence in bovine trachea. Moreover, it has been thought that the PCr / creatine kinase system plays a role in the transport of high energy phosphates from the mitochondrial compartment to the sites of energy utilization, correlating with oxidative metabolism in mammalian smooth muscle (6, 46) . Ishida and Takagi (47) demonstrated that papaverine decreased the content of PCr and ATP in guinea pig taenia coli in a concentration-dependent manner. In the present paper, papaverine and NaCN significantly decreased PCr and ATP contents below the control in the presence of CCh in the tracheal muscle. However, in comparison with NaCN, the decrease of PCr contents by papaverine was much smaller than that of muscle tension. These studies suggest that the relaxing mechanism of papaverine in phasic muscles is closely related to the inhibition of mitochondrial respiration, but it is scarcely related to it in tonic muscles.
In conclusion, it is suggested that papaverine inhibited CCh-induced muscle contraction mainly by the accumulation of cAMP due to the inhibition of PDE in bovine trachea. Moreover, it is proposed that the relaxing mechanism of papaverine in tonic muscles is related to the accumulation of cAMP and / or cGMP contents but it is not related to it in the phasic muscles.
